Safety and Efficacy Study in Adult Subjects With Acute Migraines

Completed · Phase 3 · Has a placebo group

Conditions studied: Migraine, With or Without Aura

In brief

The purpose of this study is to compare the efficacy of BHV-3000 (rimegepant) versus placebo in subjects with Acute Migraines

Key facts

Study ID
NCT03235479
Run by
Pfizer
People needed
1485
Starts
2017-07-18
Expected to finish
2018-01-26
Last updated by the study team
2023-02-16

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.